Adrecizumab-LPS Study

Clinical trial NCT03083171 · COMPLETED

Trial details

NCT number: NCT03083171
Sponsor: Adrenomed AG
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2017-01-04
Primary completion: 2017-05-24
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.